Search
forResearch 10 of 228
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone
- Physical Changes, Laboratory Parameters, and Bone Mineral Density During Testosterone Treatment in Adolescents with Gender Dysphoria
- Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess
- A Single Injection of the Anabolic Bone Agent, Parathyroid Hormone–Collagen Binding Domain (PTH–CBD), Results in Sustained Increases in Bone Mineral Density for up to 12 Months in Normal Female Mice
- Bone mineral density in hyperandrogenic amenorrhoea
- Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroids.
- Premature Graying, Balding, and Low Bone Mineral Density in Older Women and Men
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Hereditary Vitamin D Resistant Rickets: Clinical, Laboratory, and Genetic Characteristics of 2 Iranian Siblings
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →